特刊：“妇科癌症的分子特征-乳腺癌、卵巢癌、宫颈癌和子宫内膜癌 2.0”。
Special Issue: "Molecular Signatures of Gynecological Cancers-Breast Cancer, Ovarian Cancer, Cervical Cancer, and Endometrial Cancer 2.0".
机构信息
Federal Research Center "Fundamental and Translational Medicine", Timakov St. 2, 630060 Novosibirsk, Russia.
Department of Clinical Biochemistry, Zelman Faculty of Medicine and Psychology, "Novosibirsk State University", Pirogov St. 1, 630090 Novosibirsk, Russia.
出版信息
Int J Mol Sci. 2024 Oct 20;25(20):11275. doi: 10.3390/ijms252011275.
Abstract
Cancer of women's reproductive organs (gynecological cancers) and breast cancer affect women all over the world [...].
摘要
女性生殖器官（妇科）癌症和乳腺癌影响着全世界的女性[...]。
相似文献
1
Special Issue: "Molecular Signatures of Gynecological Cancers-Breast Cancer, Ovarian Cancer, Cervical Cancer, and Endometrial Cancer 2.0".特刊：“妇科癌症的分子特征-乳腺癌、卵巢癌、宫颈癌和子宫内膜癌 2.0”。
Int J Mol Sci. 2024 Oct 20;25(20):11275. doi: 10.3390/ijms252011275.
2
Molecular staging of gynecological cancer: What is the future?妇科癌症的分子分期：未来走向何方？
Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):776-89. doi: 10.1016/j.bpobgyn.2015.01.008. Epub 2015 Mar 4.
3
Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.乳腺珠蛋白A（SCGB2A2）和亲脂素B（SCGB1D2）在300多例人类肿瘤及配对正常组织中的表达分析显示，它们在妇科恶性肿瘤中共同表达。
BMC Cancer. 2006 Apr 9;6:88. doi: 10.1186/1471-2407-6-88.
4
Circulating tumor markers in gynecological tumors.妇科肿瘤中的循环肿瘤标志物。
Curr Opin Oncol. 1996 Sep;8(5):426-31. doi: 10.1097/00001622-199609000-00015.
5
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.评估六个基因panel 用于女性癌症患者血液中循环肿瘤细胞的分子检测。
BMC Cancer. 2010 Dec 3;10:666. doi: 10.1186/1471-2407-10-666.
6
MicroRNA and gynecologic cancers.微小RNA与妇科癌症
J Obstet Gynaecol Res. 2016 Jun;42(6):612-7. doi: 10.1111/jog.12995. Epub 2016 Apr 20.
7
Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.诱饵受体 3（DcR3）作为女性生殖系统恶性肿瘤肿瘤恶化的生物标志物：一项荟萃分析。
Med Sci Monit. 2016 Jun 1;22:1850-7. doi: 10.12659/msm.896226.
8
Ploidy in gynaecological cancers.妇科癌症中的倍性
Histopathology. 2005 Feb;46(2):121-9. doi: 10.1111/j.1365-2559.2005.02087.x.
9
Long Non-coding RNA NEAT1 as an Emerging Biomarker in Breast and Gynecologic Cancers: a Systematic Overview.长链非编码 RNA NEAT1 作为乳腺和妇科癌症的新兴生物标志物：系统综述。
Reprod Sci. 2021 Sep;28(9):2436-2447. doi: 10.1007/s43032-021-00481-x. Epub 2021 Feb 10.
10
The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.REG4 mRNA 在妇科癌症中的临床病理和预后意义的生物信息学分析。
J Obstet Gynaecol. 2023 Dec;43(1):2213764. doi: 10.1080/01443615.2023.2213764.
引用本文的文献
1
Bilateral Malignant Brenner Tumor of the Ovary.双侧卵巢恶性勃勒纳瘤
Case Rep Oncol. 2025 May 9;18(1):786-793. doi: 10.1159/000546358. eCollection 2025 Jan-Dec.
本文引用的文献
1
Predicting Response to Immunotargeted Therapy in Endometrial Cancer via Tumor Immune Microenvironment: A Multicenter, Observational Study.通过肿瘤免疫微环境预测子宫内膜癌对免疫靶向治疗的反应：一项多中心、观察性研究。
Int J Mol Sci. 2024 Apr 1;25(7):3933. doi: 10.3390/ijms25073933.
2
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.组织金属蛋白酶抑制剂 3：揭示其在肿瘤学中的生物学功能和意义。
Int J Mol Sci. 2024 Mar 10;25(6):3191. doi: 10.3390/ijms25063191.
3
Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.采用逻辑回归和机器学习方法的人唾液的自上而下蛋白质组学分析揭示了卵巢癌的分子特征。
Int J Mol Sci. 2023 Oct 28;24(21):15716. doi: 10.3390/ijms242115716.
4
Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.揭示乳腺癌免疫微环境的作用：窥探充满希望的前沿领域。
Int J Mol Sci. 2023 Oct 18;24(20):15332. doi: 10.3390/ijms242015332.
5
ASAP1 Expression in Invasive Breast Cancer and Its Prognostic Role.ASAP1 在浸润性乳腺癌中的表达及其预后作用。
Int J Mol Sci. 2023 Sep 20;24(18):14355. doi: 10.3390/ijms241814355.
6
SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway.SP1 诱导的长链非编码 RNA AFAP1-AS1 上调通过调控 mTOR 通路促进三阴性乳腺癌的肿瘤进展。
Int J Mol Sci. 2023 Aug 29;24(17):13401. doi: 10.3390/ijms241713401.
7
Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer.ANCO1 表达缺失调控染色质可及性并驱动早期三阴性乳腺癌进展。
Int J Mol Sci. 2023 Jul 15;24(14):11505. doi: 10.3390/ijms241411505.
8
Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and Expression in CaSki Cells.己酮可可碱通过抑制 NF-κB 通路和下调 CaSki 细胞中 表达抑制 TNF-α/TGF-β1 诱导的上皮间质转化。
Int J Mol Sci. 2023 Jun 24;24(13):10592. doi: 10.3390/ijms241310592.
9
HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?卵巢癌 HRD 检测在常规实践中的应用：我们面临的是什么？
Int J Mol Sci. 2023 Jun 22;24(13):10497. doi: 10.3390/ijms241310497.
10
Treatment options for molecular subtypes of endometrial cancer in 2023.2023年子宫内膜癌分子亚型的治疗选择
Curr Opin Obstet Gynecol. 2023 Jun 1;35(3):270-278. doi: 10.1097/GCO.0000000000000855. Epub 2023 Mar 20.
Zotero 插件